| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Bridgebio Oncology Therapeutics, Inc. (BBOT) has 12 insiders with recent SEC Form 4 filings, including 3 buys and 0 sells. BBOT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 4.53M | $34.69M | - | |
| CEO | 1.11M | $8.54M | - | |
| Dir | 138.2K | $1.06M | - | |
| Dir | 91.1K | $697.6K | - | |
| Dir | 63.4K | $485.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 13, 2024 | Chen Bihua56 | CEO And Chairperson | Buy | 2,400,000 | $10.00 | $24,000,000.00 | New | -0.3% | +3.2% |